Lupin

Lupin Limited is a prominent Indian multinational pharmaceutical company, established in 1968 and headquartered in Mumbai. It has evolved from a small startup focused on tuberculosis treatments to one of the largest global generic pharmaceutical firms, operating in over 100 countries and employing more than 24,000 people. The company is dedicated to improving health outcomes by providing affordable, high-quality medicines. Lupin's diverse product portfolio includes pharmaceuticals across various therapeutic areas such as cardiovascular, central nervous system, anti-infectives, respiratory, gastrointestinal, diabetology, pediatrics, and anti-tuberculosis. With a strong emphasis on research and development, Lupin has filed over 437 Abbreviated New Drug Applications (ANDAs) and achieved numerous first-to-file products, showcasing its commitment to innovation. Lupin serves a wide range of customers, including healthcare providers, hospitals, and pharmacies, with significant revenue generated from the U.S. generics market. The company also engages in corporate social responsibility initiatives aimed at sustainable rural development through its foundation, focusing on uplifting families in need.